20/20 Biolabs Participates In Bio Asia-Taiwan And Meets With Strategic Counterparties In Taipei, Tokyo, And Seoul To Advance East Asia Roll-Up Strategy
AIDX•20/20 Biolabs advances East Asia expansion plans
July 27 (Reuters) - 20/20 Biolabs Inc. AIDX.O:
- 20/20 Biolabs participates in Bio Asia-Taiwan and meets with strategic counterparties in Taipei, Tokyo, and Seoul to advance East Asia roll-up strategy
- 20/20 Biolabs - evaluating M&A, licensing, joint venture, and partnership opportunities in East Asia
